Jump to page content
  • Dr. Simon Hellwig receives Hentschel Prize 2022 for stroke research

    As a fellow in the BIH Charité Clinician Scientist Program at the Department of Neurology with Experimental Neurology at Charité - Universitätsmedizin Berlin, Dr. Simon Hellwig is conducting research on the early detection of serious cardiovascular events after a stroke. He has now received the €5,000 Hentschel Prize 2022 for Stroke Research for…

  • Can the neurological side effects of chemotherapy be prevented?

    Chemotherapy is often associated with severe neurological side effects. The multicenter study PREPARE led by Charité – Universitätsmedizin Berlin now aims to find out whether preventive lithium administration during chemotherapy can alleviate or even entirely prevent neurological complications in breast cancer patients. The SPARK-BIH program of…

  • QUEST Center

    Einstein Foundation Award – The 2022 Awardees

    The €500,000 Einstein Award for Promoting Quality in Research honors researchers and institutions whose work helps to fundamentally advance the quality and robustness of research findings. The recipient of this year’s international Individual Award is Canadian physician Gordon Guyatt for the development of best practices for all areas of clinical…

  • Gene Technology Report is now based at the BIH: new brochure and public event on RNA

    The monitoring and interdisciplinary research group Gene Technology Report seeks to promote an objective discourse on genetic technologies in Germany. Renowned natural scientists, social scientists, and humanities scholars present the current state of the art in the field through periodic reports and special topic volumes, taking into account…

  • Why do blood and lymphatic vessels grow unchecked? ERC Starting Grant for René Hägerling

    Anomalies in the formation of blood and lymphatic vessels are, thankfully, rare. Those who do have them face a lifetime of complications that can range from the mild to the life-threatening. To date, little is known about the causes, which means the diagnostic and treatment options are very limited. René Hägerling of the BIH Center for Regenerative…

  • What happens when leukemia cells and immune cells meet? ERC Starting Grant for Simon Haas

    Leukemia, a blood cancer, occurs when immature immune cells stop developing but keep dividing and eventually inundate the blood. There, they encounter mature and active immune cells that either recognize and kill the cancer cells or let them escape. Dr. Simon Haas, head of a BIH junior research group within the joint focus area “Single-Cell…

  • How genes and small molecules influence our personal disease risk

    Every person has an individual chemical fingerprint. The composition of small molecules in the blood, such as fats or sugars, determines how our body reacts to external influences, which diseases we are susceptible to and how severe an illness will be. In an international collaboration with partners from Cambridge (UK), scientists from the Berlin…

  • Three proteins in the blood help to early detect type 2 diabetes risk

    Scientists have used a proteomics approach to identify a three-protein signature in the blood that can improve detection of impaired glucose tolerance, and help identify individuals at high risk of developing type 2 diabetes. The research, led by scientists from the Berlin Institute of Health at Charité (BIH), Germany, and the Medical Research…

  • Making gene and immunotherapy safer: Christof von Kalle receives Outstanding Achievement Award from the European Society of Gene and Cell Therapy

    Professor Christof von Kalle, BIH Chair for Clinical Translational Sciences and Founding Director of the Clinical Study Center of the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin, has been awarded the European Society of Gene and Cell Therapy (ESGCT) Outstanding Achievement Award for his contributions to the…

  • €7.5 million for osteoarthritis prevention

    An international research consortium led by the Berlin Institute of Health at Charité (BIH) has secured funding of €7.5 million through the EU’s current Horizon Europe program. The goal of the participating scientific and clinical specialists is to prevent the pain and cartilage degeneration associated with chronic osteoarthritis by reducing the…

  • One for all – polypill reduces risk of repeat heart attacks better than single drugs alone

    Heart attack patients taking a combination “polypill” made up of the blood thinner ASA as well as substances that lower blood pressure and blood lipid concentrations were less likely to suffer another major cardiovascular event than patients taking three separate pills. That is the finding of the Europe-wide SECURE study, which was recently…

  • Million Euro Support for MyoPax

    MyoPax, a new spin-off of the Max Delbrück Center and Charité, receives a 1.3 million euros loan to jump-start its entrepreneurial activities. The start-up develops regenerative therapies for previously incurable muscle diseases using its innovative muscle stem cell technology. The BIH accelerated the spin-off activity via its Spark program.

  • Stolen DNA strengthens immune diversity

    To be able to act against pathogens, the immune system needs a huge number of matching antibodies. In a study conducted at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), the group led by BIH Professor Kathrin de la Rosa found that a "thieving" mechanism contributes to this diversity. The scientists have published…

  • BIH Academy

    Prof. Duška Dragun posthumously awarded the Berlin Medical Association’s Georg Klemperer Prize

    “Courage and exceptional dedication” are the qualities that Dr. Peter Bobbert, president of the Berlin Medical Association, sees in those who were recently awarded the Georg Klemperer Prize. Prof. Duška Dragun was honored for her significant contribution to training a new generation of young clinical scientists in the medical profession. “We know –…

  • Simon Haas receives GSCN Young Investigator Award for research on blood stem cells

    With the GSCN Awards 2022, the German Stem Cell Network recognizes outstanding stem cell researchers on their way to expand basic research and open up new avenues for therapeutic options. The "GSCN 2022 Young Investigator Award" goes to Simon Haas from the Berlin Institute of Health (BIH), the Charité and the Max Delbrück Center for Molecular…

  • Corona

    Why some people suffer more from COVID-19 than others

    A large number of people are currently contracting COVID-19. Fortunately, most of them are experiencing only mild symptoms, largely thanks to the high vaccination rate. However, in some individuals the disease takes a much more severe cause and our understanding about the underlying reasons is still insufficient. The human genome may hold a key to…

  • Corona

    What happens in the lungs during SARS-CoV-2 infection

    A Berlin-based research group led by Charité - Universitätsmedizin Berlin has succeeded in simulating SARS-CoV-2 infection in human lungs and has gained important insights into the mechanism of infection. Using living lung samples, they were able to show that the virus is capable of directly infecting the cells of the human alveoli to only a very…

  • What makes blood vessels grow?

    Blood vessels must adapt their growth to the nutrients available in their surroundings so that they can keep organs adequately supplied. A team led by Michael Potente has identified two proteins that are important for this process and published their findings in Nature Metabolism.

  • BIH welcomes the MDC’s new Scientific Director Maike Sander

    Prof. Maike Sander has been named the new Scientific Director of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), which is the Privileged Partner of the Berlin Institute of Health at Charité (BIH). The BIH Board of Directors warmly welcomes the diabetes researcher and professor of pediatrics and cellular and…

  • Charité BIH Innovation

    EpiBlok is developing a gene therapy for epilepsy

    During an epileptic seizure, groups of neurons suddenly fire all at once, leading to involuntary movements and sensations. Possibilities for helping those who suffer from epilepsy are limited. EpiBlok Therapeutics GmbH was recently founded by scientists from Charité and the Medical University of Innsbruck. The company is developing a type of gene…

  • State Secretary Judith Pirscher from the Federal Ministry of Education and Research (BMBF) visits the Berlin Institute of Health at Charité (BIH)

    On Thursday, June 9, 2022, Judith Pirscher, State Secretary at the German Federal Ministry of Education and Research (BMBF), visited the Berlin Institute of Health at Charité (BIH). As the State Secretary responsible for life sciences and Chair of the BIH Governing Board, she gained an overview of the scientific work being carried out at the BIH.

  • Millions in funding for brain simulation

    The EBRAIN-Health project, led by Prof. Dr. Petra Ritter, BIH Johanna Quandt Professor of Brain Simulation and Head of the Brain Simulation research group at the Berlin Institute of Health at Charité (BIH) and Head of Charité’s Department of Neurology and Experimental Neurology, aims to develop a decentralized, privacy-compliant research platform…

  • Ludovic Vallier grows liver tissue from stem cells

    Effective July 1, 2022, Ludovic Vallier will take up the W3 Einstein Strategic Professorship for Stem Cells in Regenerative Therapies at the Berlin Institute of Health at Charité (BIH). Vallier is an expert in pluripotent stem cells and organoids. He uses these versatile cells to grow liver cells, which allow him to study the development and…

  • Demo Day 2022 to highlight digital innovations for tomorrow’s healthcare

    On May 31, 2022, the Digital Health Accelerator Program of the Berlin Institute of Health at Charité (BIH) will celebrate its fifth anniversary. This special occasion will include talks by successful grantees and committed supporters, as well as pitches by the seven 2022 funded teams of young researchers and physicians from Charité –…